共 50 条
Oral complications in a paediatric graft versus host disease (GVHD) clinic: A retrospective study
被引:1
|作者:
Emperumal, Chitra Priya
[1
,5
]
Weller, Brett
[2
]
Okane, Sara
[3
]
Joseph, Renita
[3
]
Kharbanda, Sandhya
[3
]
Ling, Zhan
[1
]
Villa, Alessandro
[1
,4
]
机构:
[1] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Dent, San Francisco, CA USA
[3] Univ Calif San Francisco, Paediat Bone Marrow Transplant Program, San Francisco, CA USA
[4] Florida Int Univ, Miami Canc Inst, Herbert Wertheim Coll Med, Dept Translat Med,Baptist Hlth South Florida, Miami, FL USA
[5] Univ Calif San Francisco, Dept Orofacial Sci, 513 Parnassus Ave, s722, San Francisco, CA 94143 USA
关键词:
allogeneic bone marrow transplants;
oral cGHVD;
oral manifestations;
paediatric population;
CONSENSUS DEVELOPMENT PROJECT;
HEMATOPOIETIC-CELL TRANSPLANTATION;
MANAGEMENT;
CRITERIA;
TRIALS;
HEALTH;
XEROSTOMIA;
DIAGNOSIS;
SURVIVORS;
CHILDREN;
D O I:
10.1111/odi.14535
中图分类号:
R78 [口腔科学];
学科分类号:
1003 ;
摘要:
Objective: The aim of this study was to investigate the oral health status among allogeneic transplant recipients who were seen in a multidisciplinary graft-versus-host disease paediatric clinic at the University of California, San Francisco (UCSF).Methods: This was a retrospective cohort study of patients who underwent allogeneic transplants and were seen in the graft-versus-host disease paediatric clinic between January 2010 and September 2021. Demographic, medical and oral health data were recorded and analysed using descriptive statistics.Results: A total of 25 patients were seen in the paediatric graft-versus-host disease clinic (68% males) with a median age of 12 years at the time of transplant were included. Among them, 12 patients (48%) were diagnosed with oral chronic GVHD, 11 (44%) with dry mouth, four (16%) with oral pseudomembranous candidiasis, one (4%) with recrudescent Herpes Simplex Virus (HSV) infection and one (4%) with mammalian target of rapamycin-inhibitor stomatitis and were managed by the oral medicine team, accordingly with medications, such as topical steroids (44%) and anti-fungal (20%).Conclusions: HSCT recipients may present with a variety of oral complications. Patients may benefit by a multi-disciplinary approach including a dental specialist as part of the cancer care team.
引用
收藏
页码:1084 / 1090
页数:7
相关论文